You are here

remibrutinib

Novartis cues up filings for remibrutinib in chronic hives

Pharmaphorum

Fri, 05/31/24 - 10:47 am

clinical trials

Novartis' BTK inhibitor beats placebo in dermatology trial, lining up another potential indication

Fierce Biotech

Sun, 03/10/24 - 08:29 pm

hidradenitis suppurativa

clinical trials

Novartis’ urticaria drug meets all endpoints in Phase III trials

Clinical Trials Arena

Fri, 11/10/23 - 10:05 am

chronic spontaneous urticaria

clinical trials

Novartis prepares for FDA submission for its chronic hives treatment

Clinical Trials Arena

Wed, 08/9/23 - 10:15 am